Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haluk Ozen

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Tumori|July 31, 2020
Predictors of ISUP score upgrade in patients with low-risk prostate cancerHakan Bahadir Haberal, Meylis Artykov, Berk Hazir, et al.
Materials Science & Engineering. C, Materials for Biological Applications|December 19, 2016
Polyethyleneimine brushes effectively inhibit encrustation on polyurethane ureteral stents both in dynamic bioreactor and in vivoMerve Gultekinoglu, Barış Kurum, Siyami Karahan, et al.
Japanese Journal of Clinical Oncology|November 20, 2012
A preoperative prognostic model predicting recurrence-free survival for patients with kidney cancerOzgur Yaycioglu, Saadettin Eskicorapci, Erdem Karabulut, et al.
Pathology, Research and Practice|June 10, 2008
Testicular persistence of Parvovirus B19: evidence for preferential infection of germ cell tumorsKoray Ergunay, Gaye Guler Tezel, Asiye Isin Dogan, et al.
Korean Journal of Urology|August 7, 2012
Extended pelvic lymph node dissection: before or after radical cystectomy? A multicenter study of the Turkish society of urooncologyHaluk Ozen, Ozgur Ugurlu, Sumer Baltaci, et al.
Urology|January 10, 2006
Low-grade Ta (noninvasive) urothelial carcinoma of the bladderWillem Oosterlinck, Eduardo Solsona, Hideyuki Akaza, et al.
European Urology|February 18, 2005
Complexed prostate specific antigen density is better than the other PSA derivatives for detection of prostate cancer in men with total PSA between 2.5 and 20 ng/ml: results of a prospective multicenter studySinan Sözen, Saadettin Eskicorapci, Bora Küpeli, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 31, 2007
Erectile dysfunction in successfully treated lymphoma patientsSercan Aksoy, Hakan Harputluoglu, Saadettin Kilickap, et al.
World Journal of Urology|August 29, 2018
<sup>68</sup>Ga-labelled PSMA ligand HBED-CC PET/CT imaging in patients with recurrent prostate cancerElif Neslihan Akdemir, Murat Tuncel, Fadıl Akyol, et al.
Urologic Oncology|January 28, 2009
Renal cell carcinoma with inferior vena cava thrombus: the Hacettepe experienceSertac Yazici, Kubilay Inci, Cenk Yucel Bilen, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Tumori|July 31, 2020
Predictors of ISUP score upgrade in patients with low-risk prostate cancerHakan Bahadir Haberal, Meylis Artykov, Berk Hazir, et al.
Materials Science & Engineering. C, Materials for Biological Applications|December 19, 2016
Polyethyleneimine brushes effectively inhibit encrustation on polyurethane ureteral stents both in dynamic bioreactor and in vivoMerve Gultekinoglu, Barış Kurum, Siyami Karahan, et al.
Japanese Journal of Clinical Oncology|November 20, 2012
A preoperative prognostic model predicting recurrence-free survival for patients with kidney cancerOzgur Yaycioglu, Saadettin Eskicorapci, Erdem Karabulut, et al.
Pathology, Research and Practice|June 10, 2008
Testicular persistence of Parvovirus B19: evidence for preferential infection of germ cell tumorsKoray Ergunay, Gaye Guler Tezel, Asiye Isin Dogan, et al.
Korean Journal of Urology|August 7, 2012
Extended pelvic lymph node dissection: before or after radical cystectomy? A multicenter study of the Turkish society of urooncologyHaluk Ozen, Ozgur Ugurlu, Sumer Baltaci, et al.
Urology|January 10, 2006
Low-grade Ta (noninvasive) urothelial carcinoma of the bladderWillem Oosterlinck, Eduardo Solsona, Hideyuki Akaza, et al.
European Urology|February 18, 2005
Complexed prostate specific antigen density is better than the other PSA derivatives for detection of prostate cancer in men with total PSA between 2.5 and 20 ng/ml: results of a prospective multicenter studySinan Sözen, Saadettin Eskicorapci, Bora Küpeli, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 31, 2007
Erectile dysfunction in successfully treated lymphoma patientsSercan Aksoy, Hakan Harputluoglu, Saadettin Kilickap, et al.
World Journal of Urology|August 29, 2018
<sup>68</sup>Ga-labelled PSMA ligand HBED-CC PET/CT imaging in patients with recurrent prostate cancerElif Neslihan Akdemir, Murat Tuncel, Fadıl Akyol, et al.
Urologic Oncology|January 28, 2009
Renal cell carcinoma with inferior vena cava thrombus: the Hacettepe experienceSertac Yazici, Kubilay Inci, Cenk Yucel Bilen, et al.
Pageof 8